Biocomposites appoints Group Chief Financial Officer and New UK General Manager

Keele, UK, 15 June 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to announce two new appointments. Simon Greenhalgh has been appointed Group Chief Financial Officer (CFO) and Pete Webster takes up the position of UK General Manager.

Read more…

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...